There is absolutely no reason BTA shouldnt call GSK and put out a statement on this. Look at this old BTA ann below that they did in 2006. That BTA annoucement was only based on the 80/20 intention from the US govt.
Peter Cook give your good mate Whitty a call and disclose to the market the details of this USA intent to order. HAHHAA. Yea right.FULL DISCLOSURE. Nothing competitively sensitive about it as NO competion.
''US Govt intention to order a further 12.3m courses of Relenza
United States Department of Health and Human Services (HHS) statements released
late last week reveal that the HHS intends to increase its stockpile of Relenza by an
additional 12.3 million courses, taking the Relenza stockpile to 16.2 million courses.
The HHS has increased the proportion of Relenza to 20% of the total 81 million
course stockpile it intends to complete by 2008, attributing the increase in Relenza
to its favourable risk of resistance profile to Tamiflu.''
http://www.biota.com.au/uploaded/154/1021189_47usintentiontoorderaddit.pdf
- Forums
- ASX - By Stock
- usa intends to order relenza confirmed
There is absolutely no reason BTA shouldnt call GSK and put out...
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online